• All
• A
• B
• C
• D
• E
• F
• G
• H
• I
• J
• K
• L
• M
• N
• O
• P
• Q
• R
• S
• T
• U
• V
• W
• X
• Y
• Z

• Z
• Zaidi, Syed Saoud
  Indiana University
• PT-025 - DEVELOPMENT AND VERIFICATION OF A NIFEDIPINE CONTROLLED RELEASE PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL IN PREGNANCY

  
  Syed Saoud Zaidi
  Favorite
• Zhang, Rong
  Genentech
• PII-033 - EXPANDING THE USE OF REAL-WORLD DATA TO ANSWER CLINICAL PHARMACOLOGY QUESTIONS: DEVELOPMENT OF A USER-FRIENDLY DASHBOARD TO ASSESS PREVALENCE OF ORGAN IMPAIRMENT IN PATIENTS IN THE REAL-WORLD SETTING.
  Rong Zhang
  Favorite
• Zheng, Zicong
  University of Houston
• TIP-003 - EVALUATING THE IMPACT OF XIAO-CHAI-HU-TANG ON PHARMACOKINETIC BEHAVIORS OF IRINOTECAN, RALOXIFENE AND THEIR METABOLITES IN HUMANS: A RUN-IN SAFETY STUDY.
  Zicong Zheng
  Favorite
• Zhou, Jian
  Bristol Myers Squibb
• PII-101 - CHARACTERIZING EXPOSURE-RESPONSE RELATIONSHIPS OF IDECABTAGENE VICLEUCEL IN PATIENTS WITH TRIPLE-CLASS-EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA.
  Jian Zhou
  Favorite
• Zhou, Jieqiang
  University of Florida
• PII-150 - POPULATION PHARMACOKINETICS OF ENROFLOXACIN AND FLORFENICOL IN THE GIANT DANIO (DEVARIO AEQUIPINNATUS) FOLLOWING ORAL AND BATH ADMINISTRATION
  Jieqiang Zhou
  Favorite
• Zhou, Li
  Pfizer, Inc.
• PII-115 - EVALUATION OF THE EFFECT OF VEPDEGESTRANT, A PROTEOLYSIS TARGETING CHIMERA (PROTAC) ESTROGEN RECEPTOR (ER) DEGRADER, ON ROSUVASTATIN PHARMACOKINETICS (PK) IN HEALTHY ADULT PARTICIPANTS.
  Li Zhou
  Favorite
• Zhou, Lian
  ARCUS Biosciences
• LB-011 - DEVELOPMENT AND VERIFICATION OF MECHANISTIC PHYSIOLOGICALLY BASED PHARMACOKINETIC (PBPK) MODEL FOR ENZALUTAMIDE AND ITS N-DESMETHYL METABOLITE M2 AS INDUCERS OF CYP3A4
  Lian Zhou
  Favorite
• Zhu, Min
  Regeneron Pharmaceuticals, Inc.
• PII-053 - EVALUATION OF IMPACT OF PRIOR CAR T THERAPY ON PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF ODRONEXTAMAB, A CD20×CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL).
  Min Zhu
  Favorite
• Zhu, Xiujuan
  Mayo Clinic
• OAII-002 - ALCOHOL USE DISORDER PHARMACOGENOMICS: ROLE OF FNDC4 IN HUMAN NEURONAL FUNCTION.
  Xiujuan Zhu
  Favorite
• PT-010 - ALCOHOL USE DISORDER PHARMACOGENOMICS: ROLE OF FNDC4 IN HUMAN NEURONAL FUNCTION.

  
  Xiujuan Zhu
  Favorite
• Zou, Peng
  Daiichi Sankyo
• PII-198 - CLINICAL PHARMACOLOGY CONSIDERATIONS IN EXTRAPOLATION OF EFFICACY AND SAFETY FROM ADULTS TO PEDIATRICS - LESSONS LEARNED FROM PEDIATRIC PROGRAMS OF DIRECT ORAL ANTICOAGULANTS.
  Peng Zou
  Favorite